Metraipolis › archive › dc_0bcacf4fa2e4

Risk factors for oral and esophageal candidiasis during budesonide treatment in eosinophilic esophagitis patients — Europe PMC PMID:42060043

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42060043
DOI: 10.1007/s11739-[numero omesso]-y
License (as archived): solo-consultazione
Archived: 2026-11-03T00:00:27.692Z
SHA-256 of the archived text: 742fc4b3e60592333b2061395af3a34e5b4e97b384fea0aa7b31f1ea314e0d80
Stable URL of this page: https://metraipolis.com/documento/dc_0bcacf4fa2e4

How to cite

Risk factors for oral and esophageal candidiasis during budesonide treatment in eosinophilic esophagitis patients — Europe PMC PMID:42060043 — Europe PMC (en), https://europepmc.org/article/MED/42060043 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bcacf4fa2e4 (Metraipolis archive dc_0bcacf4fa2e4, sha256 742fc4b3e60592333b2061395af3a34e5b4e97b384fea0aa7b31f1ea314e0d80)

BibTeX

@misc{dc0bcacf4fa2e4,
  title = {Risk factors for oral and esophageal candidiasis during budesonide treatment in eosinophilic esophagitis patients — Europe PMC PMID:42060043},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42060043},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bcacf4fa2e4; sha256 742fc4b3e60592333b2061395af3a34e5b4e97b384fea0aa7b31f1ea314e0d80},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42060043. Agents can read the archived copy with the MCP tool read_document.